Listed

Biomarin Pharmaceutical Inc

BMRNNasdaqCIK 1048477HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$989.7m, Q2 FY2026
Operating income$110.9m, Q2 FY2026
Net income$44.8m, Q2 FY2026
Biomarin Pharmaceutical Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m581Revenue, Q3 FY2023, three months to 2023-09-30$581.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure646Revenue, Q4 FY2023, three months to 2023-12-31$646.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure649Revenue, Q1 FY2024, three months to 2024-03-31$648.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure712Revenue, Q2 FY2024, three months to 2024-06-30$712.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure746Revenue, Q3 FY2024, three months to 2024-09-30$745.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure747Revenue, Q4 FY2024, three months to 2024-12-31$747.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure745Revenue, Q1 FY2025, three months to 2025-03-31$745.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure825Revenue, Q2 FY2025, three months to 2025-06-30$825.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure776Revenue, Q3 FY2025, three months to 2025-09-30$776.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure875Revenue, Q4 FY2025, three months to 2025-12-31$874.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure766Revenue, Q1 FY2026, three months to 2026-03-31$766.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure990Revenue, Q2 FY2026, three months to 2026-06-30$989.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Cost of revenue$m128Cost of revenue, Q3 FY2023, three months to 2023-09-30$128.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure138Cost of revenue, Q4 FY2023, three months to 2023-12-31$137.9m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure125Cost of revenue, Q1 FY2024, three months to 2024-03-31$125.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure130Cost of revenue, Q2 FY2024, three months to 2024-06-30$130.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure188Cost of revenue, Q3 FY2024, three months to 2024-09-30$188.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure136Cost of revenue, Q4 FY2024, three months to 2024-12-31$136.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure152Cost of revenue, Q1 FY2025, three months to 2025-03-31$151.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure150Cost of revenue, Q2 FY2025, three months to 2025-06-30$150.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure140Cost of revenue, Q3 FY2025, three months to 2025-09-30$140.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure276Cost of revenue, Q4 FY2025, three months to 2025-12-31$275.7m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure195Cost of revenue, Q1 FY2026, three months to 2026-03-31$195.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure203Cost of revenue, Q2 FY2026, three months to 2026-06-30$202.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Research and development$m191Research and development, Q3 FY2023, three months to 2023-09-30$191.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure206Research and development, Q4 FY2023, three months to 2023-12-31$206.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure205Research and development, Q1 FY2024, three months to 2024-03-31$205.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure184Research and development, Q2 FY2024, three months to 2024-06-30$183.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure185Research and development, Q3 FY2024, three months to 2024-09-30$184.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure174Research and development, Q4 FY2024, three months to 2024-12-31$173.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure159Research and development, Q1 FY2025, three months to 2025-03-31$158.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure161Research and development, Q2 FY2025, three months to 2025-06-30$161.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure409Research and development, Q3 FY2025, three months to 2025-09-30$409.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure192Research and development, Q4 FY2025, three months to 2025-12-31$192.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure179Research and development, Q1 FY2026, three months to 2026-03-31$178.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure207Research and development, Q2 FY2026, three months to 2026-06-30$207.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Selling, general and administrative$m216Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$215.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure260Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$259.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure226Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$225.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure263Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$263.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure253Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$253.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure267Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$266.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure206Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$206.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure232Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$232.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure268Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$268.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure446Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$446.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure258Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$258.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure396Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$395.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Operating income$m30.5Operating income, Q3 FY2023, three months to 2023-09-30$30.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure27.3Operating income, Q4 FY2023, three months to 2023-12-31$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure88.5Operating income, Q1 FY2024, three months to 2024-03-31$88.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure120Operating income, Q2 FY2024, three months to 2024-06-30$120.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure114Operating income, Q3 FY2024, three months to 2024-09-30$113.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure161Operating income, Q4 FY2024, three months to 2024-12-31$161.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure224Operating income, Q1 FY2025, three months to 2025-03-31$223.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure277Operating income, Q2 FY2025, three months to 2025-06-30$276.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure(46.7)Operating income, Q3 FY2025, three months to 2025-09-30−$46.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure(44.6)Operating income, Q4 FY2025, three months to 2025-12-31−$44.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure130Operating income, Q1 FY2026, three months to 2026-03-31$129.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure111Operating income, Q2 FY2026, three months to 2026-06-30$110.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Interest expense$m3.8Interest expense, Q3 FY2023, three months to 2023-09-30$3.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure6.1Interest expense, Q4 FY2023, three months to 2023-12-31$6.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-26, accession 0001048477-24-000016. Derived: 12-month figure less the 9-month figure.Report this figure3.5Interest expense, Q1 FY2024, three months to 2024-03-31$3.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure3.6Interest expense, Q2 FY2024, three months to 2024-06-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure3.0Interest expense, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure2.6Interest expense, Q4 FY2024, three months to 2024-12-31$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure2.4Interest expense, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure2.4Interest expense, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure2.6Interest expense, Q3 FY2025, three months to 2025-09-30$2.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure2.8Interest expense, Q4 FY2025, three months to 2025-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure9.6Interest expense, Q1 FY2026, three months to 2026-03-31$9.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure60.7Interest expense, Q2 FY2026, three months to 2026-06-30$60.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Income tax$m1.3Income tax, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure(1.0)Income tax, Q4 FY2023, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure16.9Income tax, Q1 FY2024, three months to 2024-03-31$16.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure25.0Income tax, Q2 FY2024, three months to 2024-06-30$25.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure28.4Income tax, Q3 FY2024, three months to 2024-09-30$28.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure44.7Income tax, Q4 FY2024, three months to 2024-12-31$44.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure52.4Income tax, Q1 FY2025, three months to 2025-03-31$52.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure57.3Income tax, Q2 FY2025, three months to 2025-06-30$57.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure4.4Income tax, Q3 FY2025, three months to 2025-09-30$4.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure19.4Income tax, Q4 FY2025, three months to 2025-12-31$19.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure35.7Income tax, Q1 FY2026, three months to 2026-03-31$35.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure16.6Income tax, Q2 FY2026, three months to 2026-06-30$16.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Net income$m40.4Net income, Q3 FY2023, three months to 2023-09-30$40.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure20.4Net income, Q4 FY2023, three months to 2023-12-31$20.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure88.7Net income, Q1 FY2024, three months to 2024-03-31$88.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure107Net income, Q2 FY2024, three months to 2024-06-30$107.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure106Net income, Q3 FY2024, three months to 2024-09-30$106.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure125Net income, Q4 FY2024, three months to 2024-12-31$124.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure186Net income, Q1 FY2025, three months to 2025-03-31$185.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure241Net income, Q2 FY2025, three months to 2025-06-30$240.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure(30.7)Net income, Q3 FY2025, three months to 2025-09-30−$30.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure(46.6)Net income, Q4 FY2025, three months to 2025-12-31−$46.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure106Net income, Q1 FY2026, three months to 2026-03-31$105.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure44.8Net income, Q2 FY2026, three months to 2026-06-30$44.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Diluted EPS$ per share0.21Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figurenot reported0.46Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure0.55Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure0.55Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figurenot reported0.95Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure1.23Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure(0.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figurenot reported0.54Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure0.23Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Basic EPS$ per share0.21Basic EPS, Q3 FY2023, three months to 2023-09-30$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figurenot reported0.47Basic EPS, Q1 FY2024, three months to 2024-03-31$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure0.56Basic EPS, Q2 FY2024, three months to 2024-06-30$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure0.56Basic EPS, Q3 FY2024, three months to 2024-09-30$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figurenot reported0.97Basic EPS, Q1 FY2025, three months to 2025-03-31$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure1.25Basic EPS, Q2 FY2025, three months to 2025-06-30$1.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure(0.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figurenot reported0.55Basic EPS, Q1 FY2026, three months to 2026-03-31$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure0.23Basic EPS, Q2 FY2026, three months to 2026-06-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure

Balance sheet

Cash and equivalents$874.0m, Q2 FY2026
Long-term debt$3.53bn, Q2 FY2026
Shareholders' equity$6.32bn, Q2 FY2026
Biomarin Pharmaceutical Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn0.8Cash and equivalents, Q3 FY2023, at 2023-09-30$785.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure0.8Cash and equivalents, FY2023, at 2023-12-31$755.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-24, accession 0001048477-25-000007.Report this figure0.7Cash and equivalents, Q1 FY2024, at 2024-03-31$747.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure1.0Cash and equivalents, Q2 FY2024, at 2024-06-30$972.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure0.7Cash and equivalents, Q3 FY2024, at 2024-09-30$675.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure0.9Cash and equivalents, FY2024, at 2024-12-31$942.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure1.0Cash and equivalents, Q1 FY2025, at 2025-03-31$1.05bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure1.2Cash and equivalents, Q2 FY2025, at 2025-06-30$1.21bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure1.3Cash and equivalents, Q3 FY2025, at 2025-09-30$1.25bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure1.3Cash and equivalents, FY2025, at 2025-12-31$1.31bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure2.2Cash and equivalents, Q1 FY2026, at 2026-03-31$2.22bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure0.9Cash and equivalents, Q2 FY2026, at 2026-06-30$874.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Current assets$bn3.0Current assets, Q3 FY2023, at 2023-09-30$2.96bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure3.0Current assets, FY2023, at 2023-12-31$2.96bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-24, accession 0001048477-25-000007.Report this figure3.0Current assets, Q1 FY2024, at 2024-03-31$2.99bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure3.3Current assets, Q2 FY2024, at 2024-06-30$3.26bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure3.1Current assets, Q3 FY2024, at 2024-09-30$3.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure3.2Current assets, FY2024, at 2024-12-31$3.23bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure3.5Current assets, Q1 FY2025, at 2025-03-31$3.47bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure3.8Current assets, Q2 FY2025, at 2025-06-30$3.81bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure3.9Current assets, Q3 FY2025, at 2025-09-30$3.85bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure4.0Current assets, FY2025, at 2025-12-31$3.95bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure4.6Current assets, Q1 FY2026, at 2026-03-31$4.61bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure4.0Current assets, Q2 FY2026, at 2026-06-30$3.97bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Total assets$bn6.8Total assets, Q3 FY2023, at 2023-09-30$6.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure6.8Total assets, FY2023, at 2023-12-31$6.84bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-24, accession 0001048477-25-000007.Report this figure6.9Total assets, Q1 FY2024, at 2024-03-31$6.87bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure7.1Total assets, Q2 FY2024, at 2024-06-30$7.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure6.9Total assets, Q3 FY2024, at 2024-09-30$6.85bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure7.0Total assets, FY2024, at 2024-12-31$6.99bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure7.1Total assets, Q1 FY2025, at 2025-03-31$7.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure7.5Total assets, Q2 FY2025, at 2025-06-30$7.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure7.6Total assets, Q3 FY2025, at 2025-09-30$7.61bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure7.6Total assets, FY2025, at 2025-12-31$7.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure8.6Total assets, Q1 FY2026, at 2026-03-31$8.59bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure11.7Total assets, Q2 FY2026, at 2026-06-30$11.72bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Current liabilities$bn1.2Current liabilities, Q3 FY2023, at 2023-09-30$1.16bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure1.2Current liabilities, FY2023, at 2023-12-31$1.18bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-24, accession 0001048477-25-000007.Report this figure1.1Current liabilities, Q1 FY2024, at 2024-03-31$1.09bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure1.1Current liabilities, Q2 FY2024, at 2024-06-30$1.07bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure0.7Current liabilities, Q3 FY2024, at 2024-09-30$715.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure0.6Current liabilities, FY2024, at 2024-12-31$607.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure0.6Current liabilities, Q1 FY2025, at 2025-03-31$628.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure0.7Current liabilities, Q2 FY2025, at 2025-06-30$684.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure0.8Current liabilities, Q3 FY2025, at 2025-09-30$798.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure0.8Current liabilities, FY2025, at 2025-12-31$759.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure0.8Current liabilities, Q1 FY2026, at 2026-03-31$793.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure1.7Current liabilities, Q2 FY2026, at 2026-06-30$1.66bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Total liabilities$bn1.9Total liabilities, Q3 FY2023, at 2023-09-30$1.86bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure1.9Total liabilities, FY2023, at 2023-12-31$1.89bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-24, accession 0001048477-25-000007.Report this figure1.8Total liabilities, Q1 FY2024, at 2024-03-31$1.80bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure1.8Total liabilities, Q2 FY2024, at 2024-06-30$1.78bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure1.4Total liabilities, Q3 FY2024, at 2024-09-30$1.44bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure1.3Total liabilities, FY2024, at 2024-12-31$1.33bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure1.4Total liabilities, Q1 FY2025, at 2025-03-31$1.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure1.4Total liabilities, Q2 FY2025, at 2025-06-30$1.43bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure1.6Total liabilities, Q3 FY2025, at 2025-09-30$1.56bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure1.5Total liabilities, FY2025, at 2025-12-31$1.51bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure2.4Total liabilities, Q1 FY2026, at 2026-03-31$2.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure5.4Total liabilities, Q2 FY2026, at 2026-06-30$5.40bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Long-term debt$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.6Long-term debt, FY2025, at 2025-12-31$597.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure1.4Long-term debt, Q1 FY2026, at 2026-03-31$1.43bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure3.5Long-term debt, Q2 FY2026, at 2026-06-30$3.53bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Current portion of debt$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figurenot reported0.7Current portion of debt, Q2 FY2026, at 2026-06-30$658.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure
Shareholders' equity$bn4.9Shareholders' equity, Q3 FY2023, at 2023-09-30$4.90bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure5.0Shareholders' equity, FY2023, at 2023-12-31$4.95bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001048477-26-000004.Report this figure5.1Shareholders' equity, Q1 FY2024, at 2024-03-31$5.07bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure5.3Shareholders' equity, Q2 FY2024, at 2024-06-30$5.29bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure5.4Shareholders' equity, Q3 FY2024, at 2024-09-30$5.41bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure5.7Shareholders' equity, FY2024, at 2024-12-31$5.66bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure5.8Shareholders' equity, Q1 FY2025, at 2025-03-31$5.79bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure6.0Shareholders' equity, Q2 FY2025, at 2025-06-30$6.03bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure6.1Shareholders' equity, Q3 FY2025, at 2025-09-30$6.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure6.1Shareholders' equity, FY2025, at 2025-12-31$6.09bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure6.2Shareholders' equity, Q1 FY2026, at 2026-03-31$6.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure6.3Shareholders' equity, Q2 FY2026, at 2026-06-30$6.32bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure

Cash flow

Operating cash flow$168.1m, Q2 FY2026
Capital expenditure$28.8m, Q2 FY2026
Biomarin Pharmaceutical Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m136Operating cash flow, Q3 FY2023, three months to 2023-09-30$135.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001048477-24-000152. Derived: 9-month figure less the 6-month figure.Report this figure27.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$27.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure47.0Operating cash flow, Q1 FY2024, three months to 2024-03-31$47.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure119Operating cash flow, Q2 FY2024, three months to 2024-06-30$118.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001048477-25-000090. Derived: 6-month figure less the 3-month figure.Report this figure221Operating cash flow, Q3 FY2024, three months to 2024-09-30$221.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001048477-25-000107. Derived: 9-month figure less the 6-month figure.Report this figure186Operating cash flow, Q4 FY2024, three months to 2024-12-31$185.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure174Operating cash flow, Q1 FY2025, three months to 2025-03-31$174.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure185Operating cash flow, Q2 FY2025, three months to 2025-06-30$185.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001048477-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure369Operating cash flow, Q3 FY2025, three months to 2025-09-30$368.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001048477-25-000107. Derived: 9-month figure less the 6-month figure.Report this figure99.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$99.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure221Operating cash flow, Q1 FY2026, three months to 2026-03-31$220.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure168Operating cash flow, Q2 FY2026, three months to 2026-06-30$168.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001048477-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m21.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$21.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001048477-24-000152. Derived: 9-month figure less the 6-month figure.Report this figure28.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$28.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure26.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$26.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure21.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$21.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001048477-25-000090. Derived: 6-month figure less the 3-month figure.Report this figure18.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$18.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001048477-25-000107. Derived: 9-month figure less the 6-month figure.Report this figure19.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$19.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure16.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$16.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure17.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$17.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001048477-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure28.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$28.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001048477-25-000107. Derived: 9-month figure less the 6-month figure.Report this figure40.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$40.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001048477-26-000004. Derived: 12-month figure less the 9-month figure.Report this figure20.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$20.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure28.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$28.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001048477-26-000016. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)194.47m, Q2 FY2026
Biomarin Pharmaceutical Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares186Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30185,597,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001048477-23-000044.Report this figure194Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31194,363,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-26, accession 0001048477-24-000070.Report this figure195Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30194,998,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0001048477-24-000126.Report this figure191Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30191,173,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001048477-24-000152.Report this figure199Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31199,262,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-02, accession 0001048477-25-000051.Report this figure201Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30200,505,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001048477-25-000090.Report this figure197Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30197,147,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure196Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31196,474,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure197Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30197,091,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure192Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30192,032,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001048477-25-000107.Report this figure198Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31197,671,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001048477-26-000008.Report this figure194Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30194,467,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure

Shares outstanding: 193.57mShares outstanding, period not labelled, at 2026-07-28193,573,759 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001048477-26-000016.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.